The Expanding Therapeutic Utility of Botulinum Neurotoxins-Reference-Cited by-同舟云学术

The Expanding Therapeutic Utility of Botulinum Neurotoxins

Published:2018-05-18 Issue:5 Volume:10 Page:208
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Fonfria Elena,Maignel Jacquie,Lezmi Stephane,Martin Vincent,Splevins Andrew,Shubber Saif,Kalinichev Mikhail,Foster Keith,Picaut Philippe,Krupp Johannes

Funder

Ipsen

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.mdpi.com/2072-6651/10/5/208/pdf

Reference186 articles.

1. Identification and characterization of a novel botulinum neurotoxin

2. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes;Hill,2012

3. Botulinum neurotoxin D-C uses synaptotagmin I/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins

4. Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity

5. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open source in silico workflow to assist in the design of fusion proteins;Computational Biology and Chemistry;2024-12

2. Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?;Current Opinion in Pharmacology;2024-10

3. The Degradation of Botulinum Neurotoxin Light Chains Using PROTACs;International Journal of Molecular Sciences;2024-07-08

4. Botulinum neurotoxin serotype A inhibited ocular angiogenesis through modulating glial activation via SOCS3;Angiogenesis;2024-06-26

5. Improving Spasticity by Using Botulin Toxin: An Overview Focusing on Combined Approaches;Brain Sciences;2024-06-24